Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract

被引:10
作者
Aquino, Rita P. [1 ]
Auriemma, Giulia [1 ]
Conte, Giulio M. [1 ]
Esposito, Tiziana [1 ]
Sommella, Eduardo [1 ]
Campiglia, Pietro [1 ]
Sansone, Francesca [1 ]
机构
[1] Univ Salerno, Dept Pharm, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy
来源
MOLECULES | 2020年 / 25卷 / 09期
关键词
Spirulina extract; peptides; nutraceutical products; microencapsulation via spray drying; technological properties; stability; in vitro intestinal permeation; INTESTINAL-ABSORPTION; CHITOSAN; PERMEABILITY; TECHNOLOGY; ENHANCERS; POWDER;
D O I
10.3390/molecules25092086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HSE shows critical organoleptic characteristics also having poor intestinal permeability, limiting absorption when orally delivered. This research aims to overcome the critical issues through the encapsulation of HSE in Chitosan/Mannitol-(CM)-based microparticles by spray drying. The produced powders (CM-HSE) showed good process yield (approximate to 70%) and encapsulation efficiency (approximate to 100%) also having good derived flow properties as well as stability up to six months storage. The microparticles constituting the spray-dried powder resulted in an amorphous micrometric state (d(50) approximate to 14 mu m) able to retain dark colour and unpleasant smell of raw HSE. Moreover, the in vitro permeation study by Franz cell indicated that the engineered microparticles are able to enhance the permeation of HSE through an intestinal biomimetic barrier (551.13 mu g/cm(2) CM-HSE vs. 315.46 mu g/cm(2) HSE at 270 min).
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan
    Ahn, Sukyung
    Lee, In-Hyun
    Lee, Eunhye
    Kim, Hyungjun
    Kim, Yong-Chul
    Jon, Sangyong
    JOURNAL OF CONTROLLED RELEASE, 2013, 170 (02) : 226 - 232
  • [42] Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin
    Sajeesh, S.
    Bouchemal, K.
    Marsaud, V.
    Vauthier, C.
    Sharma, Chandra P.
    JOURNAL OF CONTROLLED RELEASE, 2010, 147 (03) : 377 - 384
  • [43] Development of chitosan coated calcium-alginate nanocapsules for oral delivery of liraglutide to diabetic patients
    Shamekhi, Fatemeh
    Tamjid, Elnaz
    Khajeh, Khosro
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 120 : 460 - 467
  • [44] Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery
    Harde, Harshad
    Agrawal, Ashish Kumar
    Jain, Sanyog
    NANOMEDICINE, 2014, 9 (16) : 2511 - 2529
  • [45] Development of Chitosan-tri Polyphosphate Nanomaterials for Oral Delivery of Insulin
    Devasia, Sheena
    Sukumaran, Meenu
    Kumar, Suresh J. S.
    JOURNAL OF POLYMER MATERIALS, 2017, 34 (01): : 75 - 89
  • [46] Encapsulation of insulin in chitosan-coated alginate beads:: Oral therapeutic peptide delivery
    Önal, S
    Zihnioglu, F
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2002, 30 (03): : 229 - 237
  • [47] Chitosan-coated Liposomes of Centella asiatica Extract: An In vitro Formulation Design for Oral Delivery
    Hebbar, Srinivas
    Ravi, G. S.
    Shetty, Amitha
    Dubey, Akhilesh
    ASIAN JOURNAL OF PHARMACEUTICS, 2020, 14 (04) : 677 - 689
  • [48] Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery
    Farris, Eric
    Brown, Deborah M.
    Ramer-Tait, Amanda E.
    Pannier, Angela K.
    JOURNAL OF CONTROLLED RELEASE, 2017, 249 : 150 - 161
  • [49] Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs
    Takeuchi, H
    Matsui, Y
    Sugihara, H
    Yamamoto, H
    Kawashima, Y
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 303 (1-2) : 160 - 170
  • [50] Surface-modified mucoadhesive microparticles as a controlled release system for oral delivery of insulin
    Mumuni, Momoh A.
    Kenechukwu, Frankilin C.
    Ernest, Omeje C.
    Oluseun, Adedokun M.
    Abdulmumin, Barikisu
    Youngson, Darlington C.
    Kenneth, Ofokansi C.
    Anthony, Attama A.
    HELIYON, 2019, 5 (09)